Showing results (1-10 of 170) with videos related to
Sort By:
Pageof 17
Chemico-Biological Interactions|June 9, 2015
Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculationsSobia Ahsan Halim, Zaheer-ul-Haq3 Biotech|May 14, 2017
Sources of β-galactosidase and its applications in food industryShaima Saqib, Attiya Akram, Sobia Ahsan Halim, et al.Pharmaceuticals (Basel, Switzerland)|September 28, 2021
In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic SimulationSobia Ahsan Halim, Muhammad Waqas, Ajmal Khan, et al.Plos One|April 11, 2015
3D structure prediction of human β1-adrenergic receptor via threading-based homology modeling for implications in structure-based drug designingZaheer Ul-Haq, Maria Saeed, Sobia Ahsan Halim, et al.Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Rational Design of Novel Inhibitors of α-Glucosidase: An Application of Quantitative Structure Activity Relationship and Structure-Based Virtual ScreeningSobia Ahsan Halim, Sumaira Jabeen, Ajmal Khan, et al.Fitoterapia|May 19, 2018
Antidepressant potential of novel flavonoids derivatives from sweet violet (Viola odorata L): Pharmacological, biochemical and computational evidences for possible involvement of serotonergic mechanismNasiara Karim, Imran Khan, Abeer Abdelhalim, et al.Journal of Molecular Graphics & Modelling|May 8, 2010
Benchmarking docking and scoring protocol for the identification of potential acetylcholinesterase inhibitorsZaheer-ul-Haq, Sobia Ahsan Halim, Reaz Uddin, et al.Chemistry Central Journal|May 21, 2013
A combined 3D-QSAR and docking studies for the In-silico prediction of HIV-protease inhibitorsZaheer Ul-Haq, Saman Usmani, Hina Shamshad, et al.Frontiers in Chemistry|July 17, 2020
Diterpenoids and Triterpenoids From Frankincense Are Excellent Anti-psoriatic Agents: An <i>in silico</i> ApproachSobia Ahsan Halim, Ajmal Khan, Rene Csuk, et al.Current Drug Metabolism|March 10, 2018
Therapeutic Uses of HSP90 Inhibitors in Non-Small Cell Lung Carcinoma (NSCLC)Anam Akram, Sara Khalil, Sobia Ahsan Halim, et al.Pageof 17